Hormone replacement therapy: to use or not to use?

被引:11
|
作者
Baber, RJ [1 ]
O'Hara, JL
Boyle, FM
机构
[1] Univ Sydney, Dept Obstet & Gynaecol, Fac Med, Sydney, NSW 2006, Australia
[2] Univ Sydney, No Clin Sch, Sydney, NSW 2006, Australia
关键词
D O I
10.5694/j.1326-5377.2003.tb05389.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The main indication for hormone replacement therapy (HRT) is to control menopausal symptoms and improve quality of life. Ideally, withdrawal of HRT should be attempted after 4-5 years of therapy. HRT reduces fracture risk and remains appropriate therapy for osteoporosis, particularly in women with symptoms. HRT is not appropriate for primary or secondary cardioprotection. HRT leads to a small increase in breast cancer incidence, which increases with duration of therapy and age. HRT increases the risk of thromboembolism. Patient management and therapy should be reviewed annually with risk-benefit counselling.
引用
收藏
页码:630 / 633
页数:4
相关论文
共 50 条
  • [31] Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria
    Monster, TBM
    Janssen, WMT
    de Jong, PE
    de Jong-van den Berg, LTW
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (16) : 2000 - 2005
  • [32] Use of hormone replacement therapy in women with bipolar disorder: a review
    Machado, C.
    Almeida, B.
    Fragoeiro, C.
    [J]. EUROPEAN PSYCHIATRY, 2020, 63 : S69 - S69
  • [33] Hormone replacement therapy use over a decade in an Australian population
    MacLennan, AH
    Wilson, DH
    Taylor, AW
    [J]. CLIMACTERIC, 2002, 5 (04) : 351 - 356
  • [34] How to use progestin in hormone replacement therapy: an animal experiment
    Sun, AJ
    Wang, JD
    Zhu, PD
    [J]. CHINESE MEDICAL JOURNAL, 2001, 114 (02) : 173 - 177
  • [35] Health-related behavior and the use of hormone replacement therapy
    Csizmadi, I
    Collet, JP
    Boivin, JF
    Hanley, JA
    Benedetti, A
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (02) : 65 - 71
  • [36] Impact of hormone replacement therapy use on mammographic screening outcomes
    Kerri R. Beckmann
    Gelareh Farshid
    David M. Roder
    Janet E. Hiller
    John W. Lynch
    [J]. Cancer Causes & Control, 2013, 24 : 1417 - 1426
  • [37] Perceptions of menopausal stage and patterns of hormone replacement therapy use
    Bastian, LA
    Couchman, GM
    Rimer, BK
    McBride, CM
    Feaganes, JR
    Siegler, IC
    [J]. JOURNAL OF WOMENS HEALTH, 1997, 6 (04): : 467 - 475
  • [38] Earlier Use of Hormone-Replacement Therapy May Be Beneficial
    不详
    [J]. US PHARMACIST, 2012, 37 (06) : 1 - 1
  • [39] Factors associated with climacteric symptoms and the use of hormone replacement therapy
    Stadberg, E
    Mattsson, LÅ
    Milsom, I
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (04) : 286 - 292
  • [40] Prevalence and characteristics associated with use of hormone replacement therapy in Britain
    Moorhead, T
    Hannaford, P
    Warskyj, M
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (03): : 290 - 297